ArticleMolecular cancer therapeutics2018

Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial.

Vasiliki Pelekanou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.